Number of pages:
Parameters | Details |
---|---|
Base Year |
2021 |
Historical Data |
2016-2021 |
Forecast Data |
2022-2028 |
Base Year Value (2021) |
USD million |
Forecast Value (2028) |
USD million |
CAGR (2022 to 2028) |
% |
Regional Scope |
North America, Europe, Asian Pacific, Latin America, Middle East and Africa, and ROW |
Preclinical Imaging (In-VIVO) Market is expected to reach 1401.86 million by 2027 at CAGR of 4.92%. Preclinical imaging is medical process of visualization of living animals for purpose of research , such as new medical procedure and drug development . In vivo imaging has been described as bridging the gap between in vitro exploratory and in vivo clinical research, facilitating the direct and fast transfer of preclinical studies on animal models to clinical investigation in man. Imaging modalities have long been crucial to the researcher in observing changes, either at the organ, tissue, cell, or molecular level, in animals responding to physiological or environmental changes.
In application aspect, vivo imaging is increasingly deployed across the drug development process, with applicability in target identification, compound optimisation and pre-Phase I studies. In vivo imaging has been described as bridging the gap between in vitro exploratory and in vivo clinical research, facilitating the direct and fast transfer of preclinical studies on animal models to clinical investigation in man. The key diseases/therapeutic areas targeted with in vivo preclinical imaging by survey respondents were oncology/cancer (70% targeting). This was followed by inflammatory disease/autoimmune (36% targeting), neurology / CNS / neurodegeneration/ pain (32% targeting) and then cardiovascular (25% targeting)
Imaging modalities that are non-invasive and in vivo have become especially important to study animal models longitudinally. The most suitable modalities for small-animal in vivo imaging applications are based on nuclear medicine techniques (essentially, positron emission tomography [PET] and single photon emission computed tomography [SPECT]), optical imaging (OI), computed tomography (CT), magnetic resonance imaging (MRI), magnetic resonance spectroscopy imaging (MRSI), and ultrasound
Geographically, Preclinical Imaging (In-VIVO) Market categorised in North America, Europe, China, Japan, South East Asia, India and Rest of World. North America holds the highest sale volume of market. Increased in Pharmaceutical research, New development in biotechnology, government support for various research work and advancement in technology are the prime factor driving the Preclinical Imaging (In-VIVO) Market globally. Europe and Asia –Pacific market is expected to grow at higher CAGR in forecasted years. African market expected to grow at lower rate while Middle East and South American market is expected to show constant growth rate.
Preclinical Imaging (In-VIVO) Market: Techniques Type
Preclinical Imaging (In-VIVO) Market: Vessel Type
Preclinical Imaging (In-VIVO) Market : Competitive Analysis
Report includes accurate analysis of key players with Market Value, Company profile, SWOT analysis. The Study constitutes of following key players in Preclinical Imaging (In-VIVO) Market:
Geographical analysis of Preclinical Imaging (In-VIVO) Market:
Preclinical Imaging (In-VIVO) Market Report delivers comprehensive analysis of :
Preclinical Imaging (In-VIVO) Market was valued at around USD million in 2021 & estimated to reach USD by 2028.
Preclinical Imaging (In-VIVO) Market is likely to grow at compounded annual growth rate (CAGR) of % between 2022 to 2028.
Yes, the report includes COVID 19 impact on the market.
Precise research methodology, numerous analysis models & up to date data resources to achive most accurate market values.
We can tailored the report as per your requirments & budget, Most of our clients prefer custom reports.
We have quality market data for all types of budget & so now get best out of your market research budget.
Be assured of receving satisfactory analyst support to understand research report in-detail.